Senior Managing Director, Evercore ISI
Josh Schimmer is a Senior Managing Director on Evercore ISI’s Biotech team, focusing on small, mid, and select large-cap biotechnology companies. Dr. Schimmer was ranked #1 in Institutional Investor’s All America Research Team for SMID Biotech in 2018 and was runner up in 2015 and 2016. Dr. Schimmer has 14 years of biotechnology research experience, previously at Piper Jaffray, Lazard Capital Markets, Leerink Partners, and Cowen & Company. In addition, he spent two years on the buy side at Davidson Kempner.
Dr. Schimmer received his Medical Degree and subspeciality training in Internal Medicine and Rheumatology from the University of Toronto and a Master’s of Business Administration from Harvard Business School.